Navigation Links
DUSA Pharmaceuticals to Present at Roth Capital Partners 22nd Annual OC Growth Stock Conference
Date:3/9/2010

WILMINGTON, Mass., March 9 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.®  (Nasdaq: DUSA), a specialty pharmaceutical company focused primarily on the development and marketing of its Levulan® Photodynamic Therapy (PDT) technology platform for the prevention and treatment of dermatological skin conditions, announced that Bob Doman, President and Chief Executive Officer, will present a corporate overview at the Roth 22nd Annual OC Growth Stock Conference.  The conference is being held at the Ritz-Carlton Laguna Niguel, Dana Point, California on March 15-17, 2010.  Mr. Doman is scheduled to present at 12:00 p.m. Pacific Time (3:00 p.m. Eastern Time) on March 16, 2010.  Interested parties can access the live audio webcast of the presentation at www.dusapharma.com. An archived version of the presentation will be available on the DUSA website approximately three hours following the presentation.

About DUSA Pharmaceuticals

DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company focused primarily on the development and marketing of its Levulan® photodynamic therapy (PDT) technology platform, and complementary dermatology products.  Levulan® PDT is currently approved for the treatment of Grade 1 and 2 actinic keratoses of the face and scalp.  DUSA also markets other dermatology products, including ClindaReach®.  DUSA is researching the use of broad area Levulan® PDT to treat AKs and prevent squamous cell carcinomas in immunosuppressed solid organ transplant recipients and is supporting research related to oral leukoplakia in collaboration with the National Institutes of Health (NIH).  DUSA is based in Wilmington, Mass.  Please visit our website at www.dusapharma.com.

SOURCE DUSA Pharmaceuticals, Inc.

Back to top

RELATED LINKS
http://www.dusapharma.com

'/>"/>

SOURCE DUSA Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ISTA Pharmaceuticals Receives Action Date for FDA Review of Once-Daily XiDay(TM)
2. Ampio Pharmaceuticals, Inc. Retains Redwood Consultants, LLC to Assist in Shareholder Relations and Strategic Planning
3. Charles E. Lannon Was Appointed as Vice-Chairman of the Board of Directors at Kinex Pharmaceuticals
4. Chay Enterprises Inc. Completes Merger With Repurposed Drug Developer Ampio Pharmaceuticals, Inc.
5. Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2009 Financial Results
6. Shionogi Enters Into Exclusive License Agreement With QuatRx Pharmaceuticals To Market Ospemifene
7. Isis Pharmaceuticals to Present at the Cowen and Company 30th Annual Health Care Conference
8. Anadys Pharmaceuticals to Present at the Cowen and Company Healthcare Conference
9. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2009 Financial Results
10. Vanda Pharmaceuticals Announces U.S. Patent Allowance for a Long-Acting Injectable Formulation of Fanapt(TM) (iloperidone) in the U.S.
11. Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017 NeuroVive ... ("NeuroVive") today announced positive preclinical results demonstrating ... compound for non-alcoholic steatohepatitis (NASH), in an ... NV556 has previously shown similar ... model. Today, NeuroVive,s scientists present novel data ...
(Date:4/19/2017)... VIEW, Calif. , April 19, 2017  IRIDEX ... it will release financial results for the first quarter ... 3, 2017.  The Company,s management team will host a ... 5:30 p.m. ET. Investors interested in listening ... (844) 707-0665 for domestic callers or (703) 326-3030 for ...
(Date:4/19/2017)... SAN DIEGO , April 19, 2017 /PRNewswire/ ... ("Sorrento"), an antibody-centric, clinical-stage biopharmaceutical company developing new ... today announced the closing of its previously announced ... common stock at a public offering price of ... commissions and estimated offering expenses payable by Sorrento.  ...
Breaking Medicine Technology:
(Date:4/24/2017)... Chicago, Illinois (PRWEB) , ... April 24, 2017 , ... ... home. What happened next changed her life forever. , In “Healing Tears,” James depicts ... “At the advice of my attorney, I began journaling conversations and situations throughout my ...
(Date:4/24/2017)... ... April 24, 2017 , ... ALP Nutrition®, ... supplements, announced its popular products are now available for purchase on StackedNutrition.com, a ... the use of premium natural ingredients in making all of its products. These ...
(Date:4/24/2017)... ... April 24, 2017 , ... My T Chai, a South ... are now available for purchase on RevNutrition.com, a popular website specializing in sales of ... and popularized in ancient India and Siam. It spread across Asia and Africa quickly, ...
(Date:4/24/2017)... HOUSTON, TEXAS (PRWEB) , ... April 24, 2017 ... ... service (SaaS) based healthcare compliance and credentialing solutions, today announced that Kyle Allain ... Allain leads symplr’s Cactus Provider Management sales and operations, including provider, payor and ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... tumors are expected to be diagnosed globally; approximately 25,000 of them will be ... anticipating greater use of this type of healthcare model in the diagnosis and ...
Breaking Medicine News(10 mins):